Aktiia is a company focused on providing continuous and accurate blood pressure monitoring to address hypertension, a prevalent chronic condition affecting over 1.4 billion people globally. Founded on two decades of research, Aktiia has developed a unique tool that combines optical sensors with clinically validated software algorithms to measure blood pressure at the wrist. This innovative approach enables individuals to gain insights into their blood pressure patterns and understand the underlying causes of hypertension. By delivering personalized, continuous, and medical-grade blood pressure and heart rate data, Aktiia aims to enhance patient care and empower patients, researchers, and clinicians. The company's mission is to improve the accessibility, accuracy, and actionability of blood pressure management, ultimately contributing to better health outcomes and reducing the significant mortality associated with high blood pressure.
Poppins
Venture Round in 2025
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.
Zero Point Motion
Seed Round in 2025
Zero Point Motion develops advanced inertial sensors that enable precise positioning and navigation through innovative semiconductor technology. By leveraging cavity optomechanics within a hybrid micro-electro-mechanical system and photonic integrated circuit chip, the company provides ultra-low noise readouts of acceleration and rotation. This technology combines the exceptional noise characteristics of light with the high-volume production capabilities of existing sensors used in various applications, including automotive systems, smartphones, and robotic devices. As a result, Zero Point Motion's solutions enhance the accuracy and reliability of motion tracking in numerous industries.
Lexroom.ai
Seed Round in 2025
Lexroom.ai allows lawyers to complete hours of legal research in seconds. Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters. Lexroom.ai perfectly integrates with lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities. Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
Orakl Oncology
Seed Round in 2024
Orakl Oncology specializes in expediting cancer drug discovery by employing advanced biology and AI-driven analysis. It maintains a unique collection of patient tumor avatars, integrating biological and clinical data, to create realistic tumor models that mimic real-life drug responses. By mining multi-modal experimental data and combining it with deep patient data, Orakl enables oncology companies to identify relevant targets and develop more effective treatments at an accelerated pace.
Metafuels
Series A in 2024
Metafuels is a developer of innovative sustainable aviation fuel technology, specifically designed to facilitate affordable air travel while addressing environmental concerns. The company has created aerobrew™, a scalable technology that utilizes renewable feedstocks such as green hydrogen and sustainably sourced carbon dioxide, including options from direct air capture. This process allows for efficient large-scale production of e-kerosene, overcoming the challenges and costs associated with traditional e-fuel technologies. Additionally, aerobrew™ can integrate a biogenic route that utilizes renewable cellulosic biomass, ensuring that its carbon sourcing does not compete with food production. With high selectivity and yield in sustainable aviation fuel production, Metafuels aims to significantly contribute to the decarbonization of the global aviation sector and support the industry's goal of achieving net-zero emissions by 2050.
Tozero, founded in July 2022 in Munich, Germany, by Sarah Fleischer and Dr. Ksenija Milicevic Neumann, specializes in lithium-ion battery recycling technology. The company aims to accelerate decarbonization efforts by developing a scalable and sustainable machine for recovering critical materials such as lithium, nickel, cobalt, graphite, and manganese from various battery types. By enabling industries to reintroduce these valuable raw materials into the supply chain, Tozero contributes to more sustainable practices in battery production and reduces dependency on virgin resources.
Otoqi is a company that develops an automotive management platform aimed at enhancing the entire lifecycle of vehicles. Its innovative technology offers solutions for sales, after-sales, and shared mobility, enabling mobility operators to navigate the complexities of vehicle logistics. Otoqi's platform facilitates instant ordering and provides real-time visibility and control in the buying process for both new and used cars. Additionally, it streamlines operations by efficiently transferring vehicles between various sites, agencies, and partners. The company also offers comprehensive vehicle testing and after-sales services, ensuring that customers can access a full range of solutions tailored to their needs.
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Nuclera is a biotechnology company specializing in an automated protein prototyping system aimed at enhancing drug discovery processes. Its eProtein Discovery system enables researchers to rapidly produce and test high-quality, soluble, and active proteins, significantly accelerating protein projects. By integrating technology such as cell-free protein synthesis and digital microfluidics, Nuclera provides a high-throughput platform for automated protein access. This innovative approach allows scientists to obtain reliable proteins within a short timeframe, facilitating faster progress in their research and contributing to more efficient drug development efforts.
Somagenetix
Series A in 2024
Somagenetix is a biotechnology company specializing in gene therapy aimed at treating phagocyte-related illnesses. The firm focuses on developing innovative treatments for conditions such as immunodeficiency, neurodegeneration, and cancer with brain metastases. By utilizing genetically modified phagocytes, Somagenetix seeks to improve patient outcomes through targeted therapies. Additionally, the company is engaged in the discovery and development of stem cells derived from bone marrow and therapeutic genes from lentiviral vectors. This approach enables the correction of underlying genetic defects and the transplantation of gene-corrected cells back into patients, with the goal of curing various monogenetic diseases. Through its pioneering efforts, Somagenetix aspires to be a leader in the gene therapy sector.
Neo Medical
Series B in 2024
Neo Medical SA is a medical technology company based in Villette, Switzerland, with additional offices in Germany, France, and the United States. Founded in 2013, the company specializes in developing, manufacturing, and commercializing non-constraint thoraco-lumbar spinal fusion systems for spinal surgery. Its flagship product, the Neo Pedicle Screw System, offers a range of functionalities such as reduction, compression, distraction, and screw augmentation, addressing various pathologies including degenerative conditions, tumors, and trauma. Neo Medical aims to enhance the efficiency of healthcare delivery by providing versatile and high-quality surgical solutions, thereby contributing to the ongoing pursuit of healthcare cost optimization.
Puraffinity
Series A in 2024
Puraffinity Ltd., established in London in 2015, specialises in innovative water treatment solutions. The company designs and develops precision materials, notably a sustainable adsorbent capable of removing challenging pollutants like pesticides, pharmaceuticals, and PFAS from contaminated water and wastewater. Utilising advanced supramolecular chemistry methods, Puraffinity's technology binds target chemicals selectively, enabling clients to meet stringent regulations and protect local ecosystems sustainably.
IRUBIS GmbH, founded in 2017 and headquartered in Munich, Germany, specializes in the development of advanced mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company integrates semiconductor technology with infrared spectroscopy to create instruments designed for real-time monitoring of bioprocesses, particularly in the pharmaceutical sector. Its offerings include a measurement system that enables online monitoring of glucose and lactate in bioreactors without contamination risk, as well as a range of ATR crystals that enhance the capabilities of Fourier transform infrared (FTIR) spectrometers. IRUBIS aims to set a new standard for online control in bioprocessing through its innovative MIR spectroscopy solutions, facilitating continuous monitoring and control of nutrient concentrations and other critical parameters in laboratory settings.
Cubbit is a geo-distributed cloud enabler that transforms underutilized resources at the edge of the internet into business-to-business cloud services. The company's innovative software operates on existing resources, in the cloud, or at the edge, providing a seamless single data domain and customizable hyper-resilient cloud object storage. This approach allows clients to maintain data sovereignty while significantly reducing storage costs by up to 80% and minimizing their cloud carbon footprint. Cubbit's solutions are designed to meet traditional needs such as backup, while also addressing modern requirements driven by edge computing, multi-cloud environments, and data sovereignty. By using Cubbit, businesses can quickly regain control over their data, infrastructure, and costs, effectively asserting their own rules in the cloud landscape.
Axelera AI
Series B in 2024
Axelera AI is a company focused on advancing artificial intelligence through its specialized hardware and software platforms, particularly for edge computing applications. Its flagship product, the Metis™ AI Platform, combines innovative hardware and software to offer high-performance and energy-efficient AI inference solutions. Recognized for its innovation, the platform was honored at the CES® 2024 Innovation Awards. Established in 2021, Axelera AI was incubated by Bitfury, a leader in emerging technologies, and partnered with imec, a prominent nano-technology group. The company is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices located in Belgium, Switzerland, and Italy. The team consists of experts in AI software and hardware, many of whom have backgrounds with leading AI firms and Fortune 500 companies. Axelera AI’s platform features a unique custom dataflow architecture with multicore in-memory computing, enabling clients to achieve optimal power efficiency while supporting various networks for sustainable edge applications.
Neustark
Venture Round in 2024
Neustark is a company focused on promoting sustainable construction practices by enabling zero-emissions concrete production. It captures carbon dioxide emissions from the atmosphere and transforms them into limestone, a material that can replace cement and sand, which are significant cost contributors in concrete manufacturing. Additionally, Neustark offers services that allow for the recycling of construction waste by decomposing it into its original carbonate powder and gravel components. This process not only reuses materials but also helps reduce the overall carbon footprint of concrete production, positioning Neustark as a key player in the movement towards environmentally friendly construction solutions.
C12 Quantum Electronics
Venture Round in 2024
C12 Quantum Electronics is a company based in Paris, Ile-de-France, France, founded in 2019 by Pierre and Matthieu Desjardins. The company focuses on developing reliable quantum processors utilizing carbon nanotubes, which significantly reduce error rates. This technology positions C12 Quantum Electronics as a strong candidate for noisy intermediate-scale quantum applications. In addition to building quantum computers, the company also engages in developing and accelerating experiments related to information processing systems, allowing industrial clients to leverage intermediate-scale quantum applications for enhanced computing capabilities.
Limula is a biotechnology company specializing in decentralized cell therapy production. It offers a unique platform combining a bioreactor and centrifuge into one device, patented and designed for scalable manufacturing of personalized treatments. The platform comprises hardware, software, and consumables, enabling healthcare providers to safely produce cell and gene therapies closer to patients, thereby broadening access to these highly specialized treatments.
RetinAI Medical AG, founded in 2016 and headquartered in Bern, Switzerland, focuses on developing innovative software tools for the collection, organization, and analysis of eye health data. The company offers products such as OmniViewer, which enables researchers to annotate and structure both 2D and 3D datasets for machine learning and statistical analyses, and Discovery, designed for clinical and pharmaceutical research. RetinAI aims to optimize and simplify workflows in clinics and research environments, enhancing healthcare delivery by leveraging advanced machine learning for automatic image and data analysis. Its proprietary technology significantly improves image quality and facilitates the automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies, and device manufacturers, achieving performance levels comparable to human analysis.
Bcomp Ltd. is a Fribourg-based manufacturer specializing in natural fiber composites, founded in 2003. The company produces a range of innovative products, including ampliTex, which utilizes natural flax fibers, bCores, a lightweight wood core, and powerRibs, a reinforcement material made from natural fibers. Bcomp's technologies are designed to replace traditional materials such as aluminum, carbon, or glass fiber composites, providing solutions that enhance weight efficiency, rigidity, shock absorption, and damping. The company serves various industries, including sports, automotive, acoustics, aerospace, electronics, design, and leisure. Bcomp has developed a robust portfolio of intellectual property, including patents and specific processing technologies derived from aerospace and marine applications. The company prioritizes collaboration with customers and academic partners to tailor its products to meet specific industry needs while advancing its research and development efforts.
Artiria Medical
Series A in 2024
Artiria Medical SA, established in 2019 and headquartered in Lausanne, Switzerland, specializes in developing innovative medical devices for treating vascular diseases. Its flagship product is a micro-actuated device designed to navigate deep into brain arteries, facilitating precise navigation and stroke treatment. This technology empowers catheters and guidewires, enabling surgeons to perform complex procedures with enhanced control and precision, ultimately saving lives.
Aktiia is a company focused on providing continuous and accurate blood pressure monitoring to address hypertension, a prevalent chronic condition affecting over 1.4 billion people globally. Founded on two decades of research, Aktiia has developed a unique tool that combines optical sensors with clinically validated software algorithms to measure blood pressure at the wrist. This innovative approach enables individuals to gain insights into their blood pressure patterns and understand the underlying causes of hypertension. By delivering personalized, continuous, and medical-grade blood pressure and heart rate data, Aktiia aims to enhance patient care and empower patients, researchers, and clinicians. The company's mission is to improve the accessibility, accuracy, and actionability of blood pressure management, ultimately contributing to better health outcomes and reducing the significant mortality associated with high blood pressure.
Groover is an innovative platform designed specifically for independent artists, focusing on music promotion and discovery. It has cultivated a community of 200,000 artists across more than 186 countries. The platform allows musicians to directly submit their music to media outlets, radio stations, playlists, and record labels, ensuring they receive valuable feedback from a vetted network of 3,000 music curators and professionals. With over two million feedback interactions on tracks, Groover provides artists with the opportunity to obtain honest insights and tangible sharing proposals, facilitating their growth and visibility in the competitive music industry.
Transmutex
Series A in 2024
Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.
CellVoyant
Seed Round in 2024
CellVoyant Technologies Limited is an innovative biotechnology company founded in 2021, focused on developing advanced stem cell-based therapies to address chronic diseases. The company employs an AI-first approach, utilizing live cell imaging technology to predict and optimize stem cell differentiation, which allows for the scalable and precise manufacturing of any human cell and tissue. CellVoyant's technology is rooted in pioneering research from the Carazo Salas lab at the University of Bristol, merging expertise in cell biology, computer vision, engineering, and machine learning. Led by Founder and CEO Rafael Carazo, the company aims to translate cutting-edge scientific advancements into real-world applications, addressing critical healthcare challenges. With a commitment to transforming the biotechnology landscape, CellVoyant is positioned to deliver effective, life-changing therapies to patients globally.
rready is a company that offers a SaaS platform focused on innovation management, designed to engage employees by fostering their ambition and creativity. The platform provides strategic and practical support for organizations aiming to transform their workplace culture and drive business impact. By integrating a gamified offline experience with a scalable online component, rready enhances employee-driven innovation and facilitates the execution of ideas in an enjoyable and educational manner. This approach enables clients to cultivate and expand intrapreneurship initiatives, thereby improving their employer branding and promoting a sustainable culture of innovation within their organizations.
Fractory
Venture Round in 2023
Fractory Ltd is a company that specializes in online sheet metal fabrication, providing a platform that connects engineering firms with manufacturing services. Established in 2019 and headquartered in Manchester, United Kingdom, Fractory enables users to upload CAD files, which are then matched with partner service providers based on their availability, location, and specific capabilities. The platform offers a comprehensive range of services, including laser cutting, plasma cutting, tube laser cutting, sheet metal fabrication, oxy cutting, waterjet cutting, metal bending, and surface treatment. By facilitating on-demand manufacturing, Fractory aims to streamline the production process for engineering companies, regardless of batch size, and enhance sustainability in manufacturing. The company operates in various regions, including the United States, the United Kingdom, and Nordic Europe.
Memo Therapeutics
Series C in 2023
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.
Poppins
Venture Round in 2023
Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.
Orakl Oncology
Seed Round in 2023
Orakl Oncology specializes in expediting cancer drug discovery by employing advanced biology and AI-driven analysis. It maintains a unique collection of patient tumor avatars, integrating biological and clinical data, to create realistic tumor models that mimic real-life drug responses. By mining multi-modal experimental data and combining it with deep patient data, Orakl enables oncology companies to identify relevant targets and develop more effective treatments at an accelerated pace.
Nagi Bioscience
Series A in 2023
Nagi Bioscience SA is a Swiss company based in Lausanne that specializes in developing and manufacturing an innovative automated testing device utilizing organism-on-chip technology. This device leverages the microscopic worm Caenorhabditis elegans for in vivo testing, enabling pharmaceutical, chemical, and cosmetic companies to assess the toxic and beneficial effects of various substances. By integrating fully automated in vitro handling, culture, and analysis, Nagi Bioscience's platform facilitates toxicity testing, drug discovery, and anthelmintic testing. This approach allows clients to evaluate comprehensive biological responses that can only be observed at the level of the whole organism, thereby transforming traditional testing methodologies.
MedTrace Pharma
Venture Round in 2023
MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.
DRUID AI is a company specializing in an end-to-end AI platform designed for enterprise use. Founded in 2018, the company focuses on enabling rapid development and deployment of AI agents, knowledge bases, and intelligent applications to automate business processes and enhance technology return on investment. DRUID AI's solutions facilitate personalized, secure interactions across multiple channels while integrating seamlessly with existing business systems and robotic process automation technologies. The platform leverages proprietary Natural Language Processing technology to interpret user intent, providing contextually relevant information based on behavior and preferences. This empowers developers to create natural and rich interactions between employees, customers, partners, and enterprise systems through text and voice conversations across various channels. DRUID AI has established a network of over 200 partners and serves more than 300 clients globally.
Hylomorph
Series B in 2023
Hylomorph AG is a MedTech company based in Zurich, Switzerland, founded in 2014. The company specializes in the development of advanced biomaterials aimed at improving the interface between implantable medical devices and biological tissues. Hylomorph's innovative cellulose film is designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of postoperative complications such as fibrosis, infection, and device migration. This technology is particularly relevant for use in cardiac surgery and plastic surgery, addressing critical challenges associated with implant failure. By leveraging advanced biotech and surface micro-engineering methods, Hylomorph aims to enhance patient outcomes and optimize the quality of care provided by healthcare professionals.
Puraffinity
Series A in 2023
Puraffinity Ltd., established in London in 2015, specialises in innovative water treatment solutions. The company designs and develops precision materials, notably a sustainable adsorbent capable of removing challenging pollutants like pesticides, pharmaceuticals, and PFAS from contaminated water and wastewater. Utilising advanced supramolecular chemistry methods, Puraffinity's technology binds target chemicals selectively, enabling clients to meet stringent regulations and protect local ecosystems sustainably.
Verity Studios AG, founded in 2014 and headquartered in Zurich, Switzerland, is a leading provider of indoor drone systems. The company specializes in the development of autonomous drones for various applications, including inventory tracking and live entertainment. Verity's innovative solutions allow warehouses to enhance operational efficiency by providing real-time insights that reduce costs, minimize errors, and lower environmental impact. Additionally, the company offers drone show production services for diverse events, creating captivating light displays for clients in the live events sector, such as Cirque du Soleil and major music artists. With a focus on transformative technology, Verity is at the forefront of integrating drones into both commercial and entertainment industries worldwide.
ChargeX GmbH, founded in 2017 and headquartered in Munich, Germany, specializes in the design and manufacture of modular electric vehicle charging systems. Their flagship product, Aqueduct, adapts to the daily energy demands of electric vehicles, providing efficient charging solutions tailored for residential, corporate, and other infrastructural applications. ChargeX also offers installation services, ensuring that clients can effectively integrate their charging systems into various environments, including underground parking garages and parking lots. By focusing on user data and input, ChargeX enhances the charging experience, ultimately increasing competitiveness and customer satisfaction for its clients.
TURN2X is a company focused on developing advanced technology for producing renewable natural gas (RNG). The firm specializes in creating transportable renewable energy solutions that convert electricity from renewable sources such as solar and wind into RNG. Their modular methanation reactors are designed to handle variable load changes, providing industries with a clean and sustainable alternative to fossil natural gas.
Axelera AI
Series A in 2023
Axelera AI is a company focused on advancing artificial intelligence through its specialized hardware and software platforms, particularly for edge computing applications. Its flagship product, the Metis™ AI Platform, combines innovative hardware and software to offer high-performance and energy-efficient AI inference solutions. Recognized for its innovation, the platform was honored at the CES® 2024 Innovation Awards. Established in 2021, Axelera AI was incubated by Bitfury, a leader in emerging technologies, and partnered with imec, a prominent nano-technology group. The company is headquartered in the AI Innovation Center at the High Tech Campus in Eindhoven, with research and development offices located in Belgium, Switzerland, and Italy. The team consists of experts in AI software and hardware, many of whom have backgrounds with leading AI firms and Fortune 500 companies. Axelera AI’s platform features a unique custom dataflow architecture with multicore in-memory computing, enabling clients to achieve optimal power efficiency while supporting various networks for sustainable edge applications.
ANYbotics
Series B in 2023
ANYbotics AG, founded in 2016 and based in Zurich, Switzerland, specializes in developing autonomous, legged robots designed for industrial applications. The company focuses on creating innovative robotic solutions that enhance worker safety and productivity while promoting sustainable industrial practices. ANYbotics' robots are equipped with advanced features such as docking stations, sensing capabilities, and waterproof designs, enabling them to perform various tasks, including routine inspections, asset monitoring, gas detection, and the creation of 3D models. Their technology is particularly beneficial for industries like oil and gas, power, energy, mining, processing, chemicals, transportation, and construction, where complex and hazardous environments require reliable inspection solutions. With a team of over 100 employees, ANYbotics collaborates with global technology leaders to deliver integrated robotic systems that support the operational needs of large asset operators.
EcoRobotix
Series B in 2023
EcoRobotix Ltd is a Swiss company founded in 2011, specializing in the development and manufacturing of autonomous farming machines aimed at enhancing agricultural efficiency and sustainability. The company offers an advanced robotic solution designed for the weeding of row crops, meadows, and intercropping cultures. Its flagship product features a sophisticated plant recognition system, utilizing a combination of cameras, GPS RTK, and sensors to accurately identify and locate weeds. This technology allows the robot to apply herbicides with ultra-high precision, significantly reducing chemical usage by 70-95%, which not only lowers costs for farmers but also lessens the environmental impact of conventional farming practices. By improving crop yields while minimizing resource consumption, EcoRobotix positions itself as a key player in promoting sustainable agriculture.
MultiOmic Health
Seed Round in 2023
MultiOmic Health is a company focused on addressing metabolic syndrome-related diseases through AI-enabled drug discovery. It collaborates with healthcare providers to gather and analyze de-identified patient data and bio-samples. The company's MOHSAIC® platform integrates multi-omics analysis, computational systems biology modeling, and targeted laboratory experiments to develop novel precision therapeutic concepts. These concepts are then commercialized through partnerships with established biopharma companies.
Wingtra AG is a Swiss company specializing in the manufacturing of vertical take-off and landing (VTOL) drones, particularly the WingtraOne model. Founded in 2014 and headquartered in Zürich, WingtraOne is designed for high-precision aerial data collection, serving various industries such as surveying, agriculture, forestry, and infrastructure. Since its introduction to the market in 2017, the drone has gained recognition for its capability to facilitate the digitization of environments, particularly for surveying professionals in sectors including construction, mining, environmental monitoring, and urban planning. Wingtra has established partnerships with over 50 leading surveying equipment dealers worldwide, enhancing its presence in the global market. The drone operates with WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into detailed two-dimensional maps and three-dimensional models, thereby providing valuable insights for monitoring and inspection activities across multiple industries.
Flyability
Series C in 2023
Flyability SA is a Swiss company founded in 2014 that specializes in the development and manufacturing of flying robots designed for inspecting and exploring difficult-to-reach indoor and confined spaces. Its flagship product, Elios, is a collision-tolerant drone tailored for industrial inspection, particularly in sectors such as power generation, oil and gas, and maritime infrastructures. By enabling safe operations in complex environments, Flyability helps mitigate risks associated with human inspections in dangerous locations. The company also participates in search and rescue and security applications, allowing professionals to assess emergency situations without endangering lives. In addition to its drones, Flyability offers comprehensive flying kits that include spare parts, training, and after-sales support. Its innovative approach has earned it multiple awards, including the Drones for Good Award.
Insolight
Venture Round in 2022
Insolight is an energy company founded in 2015 that specializes in the development and manufacturing of advanced solar panels. The company has achieved record efficiency levels of 29 percent for its solar modules, significantly lowering residential solar electricity costs. Insolight utilizes innovative optical technology that combines high efficiency with the ease of mounting similar to standard flat panels. The company has also demonstrated its capabilities through third-party validations, achieving 36 percent efficiency on lab prototypes and 29 percent on pre-industrial modules. Insolight's business model focuses on developing intellectual property, controlling wholesale distribution, and outsourcing manufacturing. Additionally, the company is engaged in creating photovoltaic systems aimed at reducing solar electricity costs in the agricultural sector, employing integrated tracking methods to optimize energy production based on the sun's position.
Beekeeper
Series C in 2022
Beekeeper is a mobile-first communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication streams across various shifts, locations, and languages. Its application serves as a digital workplace hub, integrating multiple operational systems and communication channels to enhance employee engagement and retention. By automating processes and minimizing dependence on paper, Beekeeper transforms traditional workplace operations, allowing frontline workers to access essential resources such as schedules and paystubs. The platform enables users to communicate instantly, share files, and assign tasks through group chats or predefined streams, all of which can be accessed securely from both desktop and mobile devices. This comprehensive approach empowers clients to improve productivity and effectively connect their teams.
Bob W is a provider of short-stay accommodation services that offers an alternative to traditional hotels. The company operates a managed marketplace of serviced apartments that combine the quality standards and amenities of a lifestyle hotel with the authenticity and functionality of a home. Each apartment is locally designed, work-friendly, and equipped with hotel linens and professional cleaning services. Additionally, the accommodations feature fully equipped kitchens, access to local gyms, and curated breakfast options. This approach allows travelers to easily find and enjoy short-stay accommodations tailored to their needs while ensuring a high standard of service and ecological mindfulness.
Orbex Space
Series C in 2022
Founded in 2015, Orbex is a leading private launch services company in Europe, specializing in the small satellite industry. The company has developed a low carbon, high-performance micro-launch vehicle that supports the deployment of satellites into polar and sun-synchronous low Earth orbits from a modern launch site in central Europe. Orbex offers a flexible core launch service along with a range of supporting services aimed at simplifying the launch process for its customers. By operating from a European location, Orbex benefits from shorter supply lines, easier communication, and reduced operational costs. The company utilizes advanced materials and in-house technologies, including rocket engines and avionics, to ensure high reliability and flexible mission profiles, enabling timely launches for small, micro, and nano-satellites.
IRUBIS GmbH, founded in 2017 and headquartered in Munich, Germany, specializes in the development of advanced mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company integrates semiconductor technology with infrared spectroscopy to create instruments designed for real-time monitoring of bioprocesses, particularly in the pharmaceutical sector. Its offerings include a measurement system that enables online monitoring of glucose and lactate in bioreactors without contamination risk, as well as a range of ATR crystals that enhance the capabilities of Fourier transform infrared (FTIR) spectrometers. IRUBIS aims to set a new standard for online control in bioprocessing through its innovative MIR spectroscopy solutions, facilitating continuous monitoring and control of nutrient concentrations and other critical parameters in laboratory settings.
Flyability
Series C in 2022
Flyability SA is a Swiss company founded in 2014 that specializes in the development and manufacturing of flying robots designed for inspecting and exploring difficult-to-reach indoor and confined spaces. Its flagship product, Elios, is a collision-tolerant drone tailored for industrial inspection, particularly in sectors such as power generation, oil and gas, and maritime infrastructures. By enabling safe operations in complex environments, Flyability helps mitigate risks associated with human inspections in dangerous locations. The company also participates in search and rescue and security applications, allowing professionals to assess emergency situations without endangering lives. In addition to its drones, Flyability offers comprehensive flying kits that include spare parts, training, and after-sales support. Its innovative approach has earned it multiple awards, including the Drones for Good Award.
tozero
Pre Seed Round in 2022
Tozero, founded in July 2022 in Munich, Germany, by Sarah Fleischer and Dr. Ksenija Milicevic Neumann, specializes in lithium-ion battery recycling technology. The company aims to accelerate decarbonization efforts by developing a scalable and sustainable machine for recovering critical materials such as lithium, nickel, cobalt, graphite, and manganese from various battery types. By enabling industries to reintroduce these valuable raw materials into the supply chain, Tozero contributes to more sustainable practices in battery production and reduces dependency on virgin resources.
German Version below: marta offers a market place for families, people in need of care and European caregivers. We believe that, on the one hand everyone has the right to receive appropriate care and to age with dignity and on the other hand caregivers should be able to do their work under fair conditions. We are working on software solutions to connect caregivers with families across Europe and we support both parties during the entire process. In our own families we have seen that the current market is characterized by non-transparent services and does not deliver adequate quality. It is out mission to change that. That is why we at marta pursue the goal of making things better by applying our software solutions to fundamentally rebuilding the "24-hour" care market. Deutsche Version: marta bietet einen Marketplatz für Familien, pflegebedürftige Menschen und europäische Pflegekräfte. Aus unserer Sicht, hat zum einen jede/r das Recht darauf, angemessene Pflege zu erhalten und in Würde zu altern und zum anderen sollten Pflegekräfte unter fairen Bedingungen ihre Arbeit machen können. Wir arbeiten an dem Bau von Softwarelösungen, um Pflegekräfte mit Familien in ganz Europa zu verbinden und während der Betreuung zu begleiten. In unseren eigenen Familien haben wir gesehen, dass der derzeitige Markt von intransparenten Dienstleistungen geprägt ist und keine angemessene Qualität liefert. Deswegen verfolgen wir bei marta das Ziel, es durch unsere Softwarelösungen besser zu machen und den Markt der "24-Stunden" Pflege grundlegend neu aufzubauen.
Luminovo
Seed Round in 2022
Luminovo GmbH, founded in 2017 and based in Munich, Germany, specializes in providing artificial intelligence consulting and solutions tailored for the electronics industry. The company offers hybrid processing services designed to simplify and expedite the development and production processes of electronic products. Luminovo's innovative software facilitates data-driven insights for electronics designers, enhancing their ability to manage supply chains effectively. It empowers manufacturers by automating quoting and procurement processes, thereby fostering collaboration within the supply chain. This approach not only accelerates the path to market for electronic products but also promotes cost efficiency and sustainability in product development. Through its comprehensive offerings, Luminovo aims to reduce the time and resources required for bringing market-ready electronic products to fruition.
Piomic Medical
Series A in 2022
Piomic Medical is a developer of a non-invasive medical device aimed at treating chronic wounds, particularly leg and foot ulcers. The company has created the COMS® One Therapy System, a portable, hand-held device that utilizes optical and magnetic stimulation technologies to promote wound healing. This device is designed to be user-friendly, featuring a single button operation, and can be utilized in both clinical settings and patients' homes. Clinical studies have demonstrated that the COMS® system is safe and effective, resulting in accelerated wound closure, reduced pain, and improved quality of life for patients. By providing a lightweight and efficient solution, Piomic Medical addresses the significant challenge posed by hard-to-heal wounds, which affect millions of individuals and impose a considerable burden on healthcare systems worldwide.
Oper is a reliable technology partner that enables lenders to leverage their mortgage offerings. The company helps credit providers to launch digital credit products in a matter of days. Credit providers can simply configure their process and start selling, by using Oper's out-of-the-box modules. The customers can integrate Fintech technologies into their process by choosing functionalities from Oper's Fintech partner app store.
Nuclera is a biotechnology company specializing in an automated protein prototyping system aimed at enhancing drug discovery processes. Its eProtein Discovery system enables researchers to rapidly produce and test high-quality, soluble, and active proteins, significantly accelerating protein projects. By integrating technology such as cell-free protein synthesis and digital microfluidics, Nuclera provides a high-throughput platform for automated protein access. This innovative approach allows scientists to obtain reliable proteins within a short timeframe, facilitating faster progress in their research and contributing to more efficient drug development efforts.
ORCA Computing
Series A in 2022
ORCA Computing Limited, founded in 2019 and located in Oxford, United Kingdom, specializes in the development of quantum computers utilizing photonic technology. The company is focused on creating scalable and flexible quantum computing systems powered by quantum memories, which enhance the storage and synchronization of quantum operations. By combining proprietary memory technology with standard telecom and optical fiber components, ORCA Computing offers a novel modular architecture that leverages the full potential of photonic computing. This innovative approach aims to unlock advanced applications across various industries, accelerate technological innovation, and significantly improve performance in quantum computing.
Invasight
Seed Round in 2022
Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.
Code Intelligence
Series A in 2022
Code Intelligence GmbH, founded in 2017 and based in Bonn, Germany, specializes in developing advanced security software for application developers. The company offers an automated application security testing platform that employs coverage-based fuzzing and symbolic code execution to help identify and rectify security vulnerabilities in code. By automating various software attack simulations, Code Intelligence enables organizations to implement continuous security testing, significantly reducing the level of expert knowledge required for setup. Their solutions are designed to enhance the reliability and security of software, serving a diverse clientele that includes major global corporations such as Bosch, Deutsche Börse Group, and Deutsche Telekom.
Therapixel
Series B in 2022
Therapixel SA is a company based in Valbonne, France, with additional locations across multiple countries, including Australia and China. Founded in 2013, Therapixel specializes in designing and developing medical image analytics software for surgeons, leveraging artificial intelligence to enhance surgical procedures. Their product portfolio includes Radvise, an automatic image reading solution; Fluid, a touchless medical image navigation system for surgery; Anywhere, a post-processing workstation; and CD-Feed, a solution for importing CDs from outpatient imaging exams. The company also focuses on AI-based software for breast cancer detection and characterization, providing healthcare professionals with pertinent information to support decision-making during surgeries while adhering to sterility constraints.
Helios.do
Seed Round in 2022
Leading sustainable banking alternative - 100% transparent and dedicated to limite climate change
Soter Analytics PTY LTD focuses on preventing musculoskeletal injuries in industrial workplaces through its innovative Soter Spine system, which combines wearable sensors and advanced analytics. The company provides devices that continuously monitor human movement, capturing health and locational data to identify at-risk movements and alert workers accordingly. By partnering with large industrial organizations, Soter integrates additional sensors, such as those for temperature and heart rate, to enhance safety and productivity. The company also offers an application that tracks long-term impacts and provides actionable recommendations for injury prevention. Founded in 2015 and based in Perth, Australia, Soter Analytics aims to set a new standard in workplace safety and ergonomics by leveraging AI-powered insights to foster a culture of safety and efficiency among workers.
Minut is a technology company established in 2014, with operations in Shenzhen, China, and Malmö, Sweden. It specializes in designing and manufacturing smart home security devices. Minut's flagship product, Point, is a camera-less device that monitors noise, temperature, motion, and other environmental factors within homes. When it detects anomalies, it sends alerts to users' smartphones, enabling them to maintain home security without compromising privacy.
holo|one is a software company developing “sphere” – the award-winning, standardized Mixed Reality (MR) platform solution. It hails from Switzerland, with offices in Zurich, the Bay Area, and Chongqing, China.
Veesion is a technology company specializing in gesture recognition for real-time detection of shoplifting within the retail sector. Founded in 2018 and based in Paris, France, Veesion utilizes deep learning algorithms to analyze footage from security cameras, identifying gestures indicative of theft. The system autonomously generates alerts that are sent to human operators for confirmation and subsequent action. This innovative software can be integrated with existing surveillance systems, allowing retailers and distributors to enhance their security measures while optimizing the allocation of security personnel. By providing an ethical and effective solution to combat shoplifting, Veesion is reshaping the standards of retail security.
Oxford Medical Products
Venture Round in 2022
Oxford Medical Products is focused on developing a breakthrough gastro-retentive hydrogel technology aimed at addressing weight loss challenges. The company has created a self-expanding capsule that occupies space in the stomach, effectively reducing hunger and promoting significant weight loss. This innovative solution is designed to expand rapidly upon ingestion, providing a prolonged feeling of satiety. The capsules gradually break down and pass naturally through the digestive system, offering an affordable and safe option for individuals seeking to manage their weight. Led by a diverse team of scientists, medical professionals, and entrepreneurs, Oxford Medical Products is dedicated to tackling one of the most pressing medical issues in today's society.
Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.
Zero Point Motion
Seed Round in 2022
Zero Point Motion develops advanced inertial sensors that enable precise positioning and navigation through innovative semiconductor technology. By leveraging cavity optomechanics within a hybrid micro-electro-mechanical system and photonic integrated circuit chip, the company provides ultra-low noise readouts of acceleration and rotation. This technology combines the exceptional noise characteristics of light with the high-volume production capabilities of existing sensors used in various applications, including automotive systems, smartphones, and robotic devices. As a result, Zero Point Motion's solutions enhance the accuracy and reliability of motion tracking in numerous industries.
9T Labs AG, founded in 2018 and based in Zürich, Switzerland, specializes in the manufacture of 3D printers that produce carbon fiber composites. The company integrates advanced software, additive manufacturing, and industry-standard materials to offer a digital composite production solution. Its proprietary Additive Fusion Technology enables the creation of lightweight structural parts with precise fiber orientation, allowing for the mass production of carbon composites at reduced costs. The intuitive design software facilitates optimal fiber placement, while automated production equipment enhances efficiency and competitiveness across the manufacturing value chain. 9T Labs’ technology simplifies the production of performance parts, making them more accessible for various applications, including drones and prosthetics.
Memo Therapeutics
Series B in 2022
Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.
Scrona specializes in micro- and nanotechnology, focusing on simplifying these advanced fields for both consumers and industries. The company has developed a three-dimensional nano drip printing technology that facilitates rapid and cost-effective production. Scrona is centered on printhead development and collaborates with partners to provide comprehensive manufacturing equipment and next-generation products. This approach enables businesses to produce printed materials of high quality at reduced costs, thereby revolutionizing the landscape of micro- and nanofabrication.
Nanoleq AG is a Swiss company founded in 2017 and based in Zurich, specializing in the development and manufacture of electric cables utilizing stretchable electronics. As a spinoff from ETH Zurich, Nanoleq focuses on integrating electronic functionality into textiles, particularly for health monitoring. The company creates soft sensors that can track vital signs such as heart rate, electrocardiograms, and breathing patterns through washable and comfortable garments. Their innovative conductive silicone technology allows for the monitoring of various physiological parameters while maintaining user comfort. Nanoleq aims to establish a standard for health-monitoring textiles, making significant strides in sectors such as healthcare, robotics, aerospace, and general electronics, while also working on further advancements in textile sensor technology.
Hylomorph
Series B in 2021
Hylomorph AG is a MedTech company based in Zurich, Switzerland, founded in 2014. The company specializes in the development of advanced biomaterials aimed at improving the interface between implantable medical devices and biological tissues. Hylomorph's innovative cellulose film is designed to prevent the formation and adhesion of fibrotic tissue, thereby reducing the risk of postoperative complications such as fibrosis, infection, and device migration. This technology is particularly relevant for use in cardiac surgery and plastic surgery, addressing critical challenges associated with implant failure. By leveraging advanced biotech and surface micro-engineering methods, Hylomorph aims to enhance patient outcomes and optimize the quality of care provided by healthcare professionals.
Medimaps Group
Venture Round in 2021
Medimaps Group is a developer of medical insights software focused on enhancing the diagnosis and treatment of osteoporosis by assessing bone microarchitecture. The company designs tools that utilize artificial intelligence to analyze imaging data from DXA, X-ray, and projected CT images, enabling healthcare professionals to evaluate bone texture effectively. By employing the trabecular bone score technique, Medimaps Group provides critical quantitative information that aids physicians in selecting optimal treatment options and monitoring patient outcomes. The company is also exploring future applications of its technology in the dental and orthopedic fields, further broadening its impact on patient care.
Beekeeper
Convertible Note in 2021
Beekeeper is a mobile-first communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication streams across various shifts, locations, and languages. Its application serves as a digital workplace hub, integrating multiple operational systems and communication channels to enhance employee engagement and retention. By automating processes and minimizing dependence on paper, Beekeeper transforms traditional workplace operations, allowing frontline workers to access essential resources such as schedules and paystubs. The platform enables users to communicate instantly, share files, and assign tasks through group chats or predefined streams, all of which can be accessed securely from both desktop and mobile devices. This comprehensive approach empowers clients to improve productivity and effectively connect their teams.
Kiutra
Venture Round in 2021
Kiutra GmbH, founded in 2018 and based in Munich, Germany, specializes in the development of refrigeration solutions, particularly for cryogen-free cooling applications. The company focuses on providing easy-to-use, turn-key cryostats that facilitate low-temperature investigations of material samples, thereby accelerating the development and testing of quantum hardware and related electronics. Kiutra's innovative cooling platforms achieve continuous sub-Kelvin temperatures without relying on liquid cooling media, such as helium-3, which is both rare and costly. This technology is essential for enabling cryogenic conditions in a compact and cost-efficient manner, making it applicable for advanced fields like quantum computing, quantum communications, and quantum sensing. By offering efficient cooling solutions, Kiutra supports research and industry customers in their pursuit of scalable quantum technologies.
PathoQuest
Series B in 2021
PathoQuest SAS, a spin-off from Institut Pasteur, is a biotechnology company specializing in advanced pathogen detection through metagenomics. The company employs next-generation sequencing (NGS) based testing to provide actionable reports for clinicians, biologists, and quality assurance managers in the biopharmaceutical industry. PathoQuest's proprietary sample preparation methods and extensive database of pathogen genomic information address current limitations in infectious agent detection. Their Viral Safety testing service, aimed at biopharmaceutical companies, has already generated revenue from several major firms, showcasing the company’s innovative approach to molecular diagnostics.
Comgy
Venture Round in 2021
Comgy GmbH, founded in 2017 and based in Berlin, Germany, specializes in digital metering solutions for the housing and energy sectors. The company offers a range of products including a sub-metering solution that enables users to efficiently read meters, alongside sensors and smoke alarms. Comgy provides a Meter Gateway Management application, which acts as a control center for remote device configuration and data processing, as well as a Meter Installation Manager application for the digital registration of radiator measurements, supported by photographic documentation. Additionally, its Polyglot gateway facilitates encrypted communication between meters, sensors, and its customer platform. Comgy's technology enhances the measurement, visualization, and billing processes of heat, water, and electricity consumption in real estate, promoting transparency and facilitating energy savings.
Groover
Venture Round in 2021
Groover is an innovative platform designed specifically for independent artists, focusing on music promotion and discovery. It has cultivated a community of 200,000 artists across more than 186 countries. The platform allows musicians to directly submit their music to media outlets, radio stations, playlists, and record labels, ensuring they receive valuable feedback from a vetted network of 3,000 music curators and professionals. With over two million feedback interactions on tracks, Groover provides artists with the opportunity to obtain honest insights and tangible sharing proposals, facilitating their growth and visibility in the competitive music industry.
Aktiia is a company focused on providing continuous and accurate blood pressure monitoring to address hypertension, a prevalent chronic condition affecting over 1.4 billion people globally. Founded on two decades of research, Aktiia has developed a unique tool that combines optical sensors with clinically validated software algorithms to measure blood pressure at the wrist. This innovative approach enables individuals to gain insights into their blood pressure patterns and understand the underlying causes of hypertension. By delivering personalized, continuous, and medical-grade blood pressure and heart rate data, Aktiia aims to enhance patient care and empower patients, researchers, and clinicians. The company's mission is to improve the accessibility, accuracy, and actionability of blood pressure management, ultimately contributing to better health outcomes and reducing the significant mortality associated with high blood pressure.
Seervision
Funding Round in 2021
Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.
Scewo AG, founded in 2017 and headquartered in Winterthur, Switzerland, specializes in the design and manufacture of innovative electric wheelchairs tailored for individuals with mobility impairments. The company has developed a unique stair-climbing wheelchair that features a combination of wheels and tracks, which allows users to navigate various terrains and obstacles, including curbs and uneven surfaces. With an active control system that ensures stability and balance, the wheelchair can be operated through a joystick or a shift in body weight, enabling users to maintain independence and enhance their mobility in everyday life.
EstateGuru
Series A in 2021
EstateGuru is a leading Pan-European marketplace that specializes in facilitating property-backed loans for small and medium-sized enterprises (SMEs) and offering investment opportunities to a global investor base. The company aims to create a digital and borderless ecosystem for real estate financing across Europe and beyond. By connecting various service providers, SMEs, and investors, EstateGuru provides a unique, seamless, and cross-border digital service that differentiates it from traditional financial institutions. The platform enhances investment returns for investors while expanding access to financing for borrowers, effectively bypassing conventional banking channels. Headquartered in Tallinn, Estonia, EstateGuru employs a diverse team of 117 professionals across multiple locations, including Berlin, Manchester, Helsinki, Yerevan, Riga, and Vilnius.
Fractory Ltd is a company that specializes in online sheet metal fabrication, providing a platform that connects engineering firms with manufacturing services. Established in 2019 and headquartered in Manchester, United Kingdom, Fractory enables users to upload CAD files, which are then matched with partner service providers based on their availability, location, and specific capabilities. The platform offers a comprehensive range of services, including laser cutting, plasma cutting, tube laser cutting, sheet metal fabrication, oxy cutting, waterjet cutting, metal bending, and surface treatment. By facilitating on-demand manufacturing, Fractory aims to streamline the production process for engineering companies, regardless of batch size, and enhance sustainability in manufacturing. The company operates in various regions, including the United States, the United Kingdom, and Nordic Europe.
Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.
Humanoo is a digital health platform aimed at enhancing the physical and mental well-being of employees and insurance clients. The platform offers customized programs and innovative eHealth solutions in areas such as fitness, physiotherapy, yoga, mindfulness, and nutrition, helping users achieve their health goals. By providing comprehensive decentralized analysis, Humanoo enables companies and insurers to gain insights into the health of their employees or clients, facilitating measurable improvements. The team, comprised of 65 professionals from 15 countries, includes software developers, designers, marketing and sales specialists, as well as health and wellness experts such as sports scientists, nutritionists, yoga instructors, and physiotherapists. Humanoo's mission is to motivate individuals to maintain a healthy lifestyle and improve their overall productivity.
Salonkee S.A. is a software development company based in Luxembourg, specializing in an online platform for booking salon appointments. Founded in 2016, Salonkee offers a user-friendly, SaaS-based reservation system tailored for the hair and cosmetics sectors. The platform allows users to efficiently search for services or salons, manage appointments, and receive automated reminders via email and SMS. Additionally, Salonkee provides features such as digital calendar management, stock management, and business development statistics, enhancing customer management and streamlining operations for salons. By combining convenience and automation, Salonkee empowers users to take control of their scheduling needs while providing salons with essential tools for effective business management.
Otoqi is a company that develops an automotive management platform aimed at enhancing the entire lifecycle of vehicles. Its innovative technology offers solutions for sales, after-sales, and shared mobility, enabling mobility operators to navigate the complexities of vehicle logistics. Otoqi's platform facilitates instant ordering and provides real-time visibility and control in the buying process for both new and used cars. Additionally, it streamlines operations by efficiently transferring vehicles between various sites, agencies, and partners. The company also offers comprehensive vehicle testing and after-sales services, ensuring that customers can access a full range of solutions tailored to their needs.
Byrd is a logistics company that operates a fulfillment network designed to connect online merchants with an international warehouse system. This enables retailers to provide advanced shipping options globally without the need to establish their own logistics infrastructure. The company’s platform seamlessly integrates with major e-commerce systems, allowing retailers to enhance their service offerings and improve customer proximity. Byrd's technology-driven solution facilitates real-time stock tracking and first-mile shipping services, including item pick-up and packaging, accessible via a mobile application. This comprehensive approach aims to support both private and business customers in efficiently managing their shipping needs.
Threatray
Seed Round in 2021
Threatray is a cybersecurity company that specializes in code-based threat intelligence through its innovative malware threat search and analytics software. By creating searchable and correlatable repositories of extensive malware data, Threatray equips enterprise security and incident response teams with the necessary tools to gain a comprehensive understanding of cyber threats. The company's advanced analytics capabilities allow for in-depth analysis of data streams at the code level, facilitating the detection of similarities with known threats and the rapid identification of previously unknown malicious artifacts. This enables organizations to enhance their defenses against data leaks and better protect sensitive information.
EcoRobotix
Venture Round in 2021
EcoRobotix Ltd is a Swiss company founded in 2011, specializing in the development and manufacturing of autonomous farming machines aimed at enhancing agricultural efficiency and sustainability. The company offers an advanced robotic solution designed for the weeding of row crops, meadows, and intercropping cultures. Its flagship product features a sophisticated plant recognition system, utilizing a combination of cameras, GPS RTK, and sensors to accurately identify and locate weeds. This technology allows the robot to apply herbicides with ultra-high precision, significantly reducing chemical usage by 70-95%, which not only lowers costs for farmers but also lessens the environmental impact of conventional farming practices. By improving crop yields while minimizing resource consumption, EcoRobotix positions itself as a key player in promoting sustainable agriculture.
Sympatient
Seed Round in 2021
Sympatient GmbH is a digital therapeutics company based in Hamburg, Germany, specializing in virtual reality-based psychotherapy solutions for anxiety disorders. Established in 2017, the company develops medical applications aimed at enhancing mental health through innovative technologies. Sympatient offers two primary products: Otemi, which provides users with tasks and exercises to manage stress and promote relaxation, and Invirto, an anxiety therapy application that delivers therapeutic information and strategies, allowing patients to address their anxiety disorders independently from home. Additionally, Sympatient provides a CE-certified medical device for individuals diagnosed with anxiety disorders. By integrating technology with therapeutic practices, the company aims to make mental health treatment more accessible and personalized.
Stake is a digital platform that facilitates real estate investment, allowing individuals to invest in income-generating rental properties quickly and easily. The platform aims to modernize real estate investment by making it accessible to a broader audience. Stake achieves this by breaking down properties into smaller, investable shares, thereby enabling users to purchase stakes in residential properties. This approach not only democratizes real estate investment but also enhances transparency and profitability for investors. Through its innovative model, Stake provides a streamlined way for individuals to engage in the real estate market without the complexities traditionally associated with property investment.
Fineheart
Series B in 2021
Fineheart is a France-based medical device company specializing in innovative technologies for cardiovascular care. It focuses on the development of implantable cardiac devices aimed at treating cardiovascular diseases. The company's flagship product is a novel, wirelessly powered, fully implantable mechanical circulatory support device. This device is designed to optimize cardiac output while preserving the heart's natural contractility, thereby enabling patients to restore normal cardiac function. Fineheart's technology aims to improve the quality of life for heart failure patients, allowing them to return to normal daily activities.
EarlySight
Seed Round in 2021
EarlySight SA is a Swiss medical device company established in 2016 and headquartered in Lausanne. It specializes in developing advanced imaging technology to aid in the early detection and treatment of eye diseases. The company's innovative eye fundus camera utilizes cellular-level imaging and transscleral illumination to provide detailed images of the retina, allowing for the detection of minor structural changes. This technology enables eye specialists to monitor treatment effects rapidly and non-invasively, enhancing their ability to visualize the morphology of retinal cells. EarlySight aims to bring its cutting-edge solutions to clinics, thereby improving patient outcomes in ophthalmology.
Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.
rready is a company that offers a SaaS platform focused on innovation management, designed to engage employees by fostering their ambition and creativity. The platform provides strategic and practical support for organizations aiming to transform their workplace culture and drive business impact. By integrating a gamified offline experience with a scalable online component, rready enhances employee-driven innovation and facilitates the execution of ideas in an enjoyable and educational manner. This approach enables clients to cultivate and expand intrapreneurship initiatives, thereby improving their employer branding and promoting a sustainable culture of innovation within their organizations.
Onward
Convertible Note in 2021
Onward is a company focused on developing mobile applications and online platforms that assist users in modifying compulsive behaviors related to technology and financial management. It combines data science and artificial intelligence to create personalized programs aimed at addressing issues such as excessive screen time, social media use, gambling, and spending habits. The company also offers financial wellness solutions, including direct savings plans and emergency lending options to help individuals build financial security. Established in 2015 and based in Los Angeles, California, Onward's mission centers around restoring a balance between technology and life by providing accessible and non-judgmental resources for behavior change. Through collaboration with clinical advisors from UCLA, Onward seeks to utilize advanced behavioral science to reach a broad audience globally.